Siemens Healthineers and HeartFlow Collaborate to Provide FFRct Analysis After Coronary CTA

 

March 16, 2017—Siemens Healthineers and HeartFlow, Inc. announced that they have entered into a global collaboration agreement to provide a comprehensive, noninvasive solution to support the diagnosis and management of patients with suspected coronary artery disease (CAD). HeartFlow's fractional flow reserve CT (FFRct) personalized medical technology, which aids in the diagnosis and treatment of CAD, will be used to help achieve Siemens Healthineers' mission of enabling health care providers to meet current challenges and excel in their respective environments.

The collaboration’s joint solution pairs CT scanners from Siemens Healthineers with the HeartFlow FFRct Analysis, the first noninvasive technology to provide insight into both the extent of CAD and the impact that disease has on blood flow to the heart.

Using CT images, the HeartFlow FFRct Analysis creates a personalized three-dimensional model of each patient’s arteries, and computer algorithms then simulate blood flow and assess the impact of arterial blockages. The combined clinical pathway of coronary CTA and the HeartFlow FFRct Analysis offers actionable information that helps physicians determine each patient’s optimal course of treatment.

According to the companies, published clinical data demonstrate that use of the HeartFlow FFRct Analysis may prevent unnecessary invasive angiograms.

The United States is the initial commercial focus of this collaboration agreement, and the two companies plan to expand their efforts to additional geographic markets in the future.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.